Home » Dutch startup Nextkidney develops world’s first portable hemodialysis device for kidney patients; plans 2024 launch

Dutch startup Nextkidney develops world’s first portable hemodialysis device for kidney patients; plans 2024 launch

by admin

Bussum, Nextkidney, a medical technology company based in the Netherlands, has announced that it has developed the Neokidney, the world’s first portable hemodialysis machine.

According to the Dutch company, Neokidney is in the final stages of development and will go on sale in the Netherlands by 2024. The company has already started a safety trial in Singapore in April this year and plans clinical trials in France and the Netherlands this fall.

How to improve open source security?

Follow these three steps on your way to stronger security practices.show more
Follow these three steps on your way to stronger security practices.hide details

“These steps are required for market approval in Europe, followed by approval in the United States,” the company said in a press release.

The Next Kidney: Making Hemodialysis Treatment More Accessible

When kidney damage progresses to kidney failure, patients have two treatment options: kidney transplantation or dialysis.

Each year, 2.8 million people worldwide undergo dialysis treatment. However, hemodialysis is very demanding in terms of time and intensity and has a dramatic impact on the lives of kidney disease patients.

next kidney An initiative of the Dutch Kidney Foundation to improve patient freedom and quality of life.

To improve the lifestyles of patients suffering from renal failure, the company has teamed up with Dutch health insurance companies CZ, Zilveren Kruis, Menzis and professional developers to develop Neokidney to help patients independently undergo dialysis Did.

CZ CEO Joep de Groot said: Portable artificial kidneys also reduce medical costs. This unique dialysis machine will thereby help make Dutch healthcare more widely accessible to everyone. “

next kidney new kidney
Image Credits: Next Kidney

Nextkidney claims to give patients freedom, improve quality of life and extend life expectancy. In addition, treatment costs are reduced as less care support and dialysate are required.

The development of “NeoKidony” is being carried out at NextKidney’s laboratories in Lausanne and Singapore.

To accelerate market adoption, Oneplanetcrowd launched a Nextkidney crowdfunding campaign to raise between €1M and €5M. As of this writing, he has raised €1.9 million from 760 funders.

Half of the staff will be leaving soon!

Here’s how to keep them. check it out!show more
Here’s how to keep them. check it out! hide details

You may also like

Leave a Comment